| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0063 | 0.9 |